Acoustic-Driven Technologies Poised to Support Embodied Intelligence and Health Robotics Applications in a Multi-Billion-Dollar Brain–Computer Interface Market The Company stated that these ...

Invasive BCI Solutions, Growing Medical End-Use Adoption, and Rising Government Focus on Neurotechnology Propel Market Expansion.Austin, United States, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Brain Computer ...

What are brain-computer interfaces? Brain-computer interfaces (BCIs) are devices that allow for the action or control of an external device from brain signals. These technologies have a broad range of ...

Brain-computer interface technology has long belonged to the realm of science fiction, but it’s quickly emerging as a real-world innovation with the potential to transform how we live, work and ...

China’s medical regulator has granted a world-first commercial green light to a brain-computer interface, with a system ...

China could see brain-computer interface (BCI) technology move into practical public use within three to five years as products mature, a leading BCI expert ...

Whether it’s jacking into the Matrix or becoming a Na’avi in Avatar, connecting brains to computers is a science-fiction trope that I never thought I’d see become a reality. But increasingly, BCIs ...

Brain-computer interface, an innovative technology frontier that establishes a direct link between the human brain and ...

China's National Medical Products Administration (NMPA) approved the registration application for the innovative product of Neuracle Technology's implantable brain-computer interface hand motor ...

A new brain implant stands to transform human-computer interaction and expand treatment possibilities for neurological conditions such as epilepsy, spinal cord injury, ALS, stroke, and ...

Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and memory impairment with an insidious and irreversible pathological process. As ...

Neuralink’s first brain implant in a human patient took place in January 2024, but the details of what the company’s clinical trial actually requires of participants, regulators, and the company ...